Pfizer’s JAK/TEC inhibitor Litfulo has been ... Given as a once-daily tablet, Litfulo (ritlecitinib) has been recommended by cost-effectiveness agency NICE for use in people aged 12 and over.

Eli Lilly and Incyte have another rival in the rear-view mirror for Olumiant in alopecia areata after Pfizer reported that its ritlecitinib improved scalp hair regrowth in a late-stage trial.

The daily pill, called ritlecitinib or litfulo ... including a reduced price from the manufacturer Pfizer. Without a discount, a packet of 30 capsules would normally cost almost £1,000.